Atlas Trials

A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

Clinical trial NCT04007367 · TERMINATED

Trial details

NCT number
NCT04007367
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2019-08-06
Primary completion
2020-01-06
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.